Innere leichtsinnig Verschiebung ioannis trougakos Habe gedacht MwSt bevorzugen
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Frontiers | Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection | Immunology
Loop | Ioannis Trougakos
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors - The Breast
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Olive Bioactives: applications and prospects | LE STUDIUM
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts | Scientific Reports
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
Tweets with replies by Jean-Michel Escoffre (@JMEscoffre31) / Twitter
Ioannis Trougakos
Blood transcriptomes of anti-SARS-CoV2 antibody positive healthy individuals with prior asymptomatic versus clinical infection | medRxiv
Home
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Third Dose of the BNT162b2 Vaccine Results in Very High Levels of Neutralizing Antibodies Against SARS‐CoV‐2; Results of a Prospective Study in 150 Health Professionals in Greece - Terpos - - American
Ioannis Trougakos * - AD Scientific Index 2022
Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy - Kastritis - - American Journal of Hematology - Wiley Online Library
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients,Cell Reports - X-MOL
University of Athens | Tascmar
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Greece – Mu.Ta.Lig – COST ACTION CA15135
Cardiotoxicity Due to Proteasome Dysfunction | Bioimaging-GR, Virtual Laboratory
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients | BMC Medicine | Full Text
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places